| Novartis Pharma Schweiz AG - Opatanol, Augentropfen |
| 56175 | | 01 | | Opatanol | | Augentropfen | | S01GX09 | | Olopatadine | | 29.04.2003 | | |
|
| Composition |
| olopatadinum 1 mg ut olopatadini hydrochloridum, benzalkonii chloridum 0.1 mg, natrii chloridum, dinatrii phosphas dodecahydricus corresp. phosphas 3.34 mg, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua purificata, q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Eye drops | | | | | | | | Active Agent | Dose |
|---|
| Olopatadine | 1 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Olopatadine | 1 mg |
| | | | Inactive agents | Dose |
|---|
| | | | Aqua Purificata | | | Benzalkonium Chloride | 0.1 mg/ml | | Disodium Phosphate Dodecahydrate | | | Sodium Chloride | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 5 ml | 7.46 | 17.35 | B | SL | No |
|
